Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,981–9,000 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Slenderella Compound Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2/Theanine/Mannitol 15 mg/6 mg/75 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1731-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2/GHRP-6 Mannitol 9 mg/9 mg/9 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1726-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1715-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2 9 mg-6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1728-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1727-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin/Ipamorelin 18 mg/15 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1759-18

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Reck Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1459-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1342-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Pyridoxine 100 mg/mL, 30 mL MDV Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1614-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin E1 80 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1337-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin E1 40 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1347-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phosphate Buffer Solution 0.05 m Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-0912-20

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1432-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenol 5% and Glycerin Aqueous Solution 10 mL Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1431-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV,Pharm D Solutions, Houston, Texas --- NDC 69699-1203-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 1 mg/mL a) 10 mL Injectable NDC 69699-1501-10; b) 30 mL Injectable NDC 69699-1501-30, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Magnesium 40 gm/ns 1000 mL IV, Pharm D Solutions, Houston, Texas --- NDC 69699-0904-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.